We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

33 hedge funds and large institutions have $6.57M invested in Windtree Therapeutics Inc in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,037% more call options, than puts

Call options by funds: $557K | Put options by funds: $49K

13% more capital invested

Capital invested by funds: $5.83M → $6.57M (+$743K)

3% less funds holding

Funds holding: 34 → 33 (-1)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
8
Closed
3
Calls
$557K
Puts
$49K
Net Calls
+$508K
Net Calls Change
+$174K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$27.2K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$22.8K
3
Renaissance Technologies
Renaissance Technologies
New York
+$18.1K
4
Simplex Trading
Simplex Trading
Illinois
+$13.9K
5
Group One Trading
Group One Trading
Illinois
+$6.49K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$285K
2
Millennium Management
Millennium Management
New York
-$102K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$49.9K
4
Walleye Trading
Walleye Trading
New York
-$9K
5
TRCT
Tower Research Capital (TRC)
New York
-$4.95K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$1.5M – – –
DCM
2
DAFNA Capital Management
California
$1.03M – – –
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$896K +$22.8K +9,420 +2%
SM
4
Sabby Management
Florida
$866K -$285K -117,843 -21%
BBA
5
Baker Bros. Advisors
New York
$492K – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$438K -$49.9K -20,657 -8%
Vanguard Group
7
Vanguard Group
Pennsylvania
$384K +$5.75K +2,380 +1%
BIT
8
BlackRock Institutional Trust
California
$367K – – –
Millennium Management
9
Millennium Management
New York
$178K -$102K -42,049 -31%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$105K – – –
Deutsche Bank
11
Deutsche Bank
Germany
$83K -$2.39K -988 -2%
Renaissance Technologies
12
Renaissance Technologies
New York
$64K +$18.1K +7,508 +29%
RFS
13
Rockefeller Financial Services
New York
$53K – – –
UBS Group
14
UBS Group
Switzerland
$31K +$27.2K +11,234 +241%
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$23K – – –
WS
16
Wedbush Securities
California
$21K – – –
Group One Trading
17
Group One Trading
Illinois
$11K +$6.49K +2,685 +96%
Simplex Trading
18
Simplex Trading
Illinois
$11K +$13.9K +5,756 New
Morgan Stanley
19
Morgan Stanley
New York
$8K -$341 -141 -3%
BA
20
BlackRock Advisors
Delaware
$5K – – –
BFA
21
BlackRock Fund Advisors
California
$4K +$309 +128 +7%
TRCT
22
Tower Research Capital (TRC)
New York
$1K -$4.95K -2,047 -82%
BAM
23
Brave Asset Management
New Jersey
$1K -$3.79K -1,570 -68%
Wells Fargo
24
Wells Fargo
California
$1K -$418 -173 -20%
Bank of America
25
Bank of America
North Carolina
$1K +$1.35K +560 +747%
1
2

WINT Hedge Fund Activity: Q2 2016 in Review

33 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2016, worth a combined $6.57M — up 13% from $5.83M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of WINT and 2 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 7 added.

The largest buyer was UBS Group, adding an estimated $27.2K. The largest seller was Sabby Management, cutting an estimated $285K.

  • 33 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2016, down from 34 in Q1 2016.
  • Funds reported $6.57M of Windtree Therapeutics Inc stock for Q2 2016, up 13% quarter-over-quarter.
  • 2 funds opened new Windtree Therapeutics Inc positions in Q2 2016 and 3 closed out, a net change of -1 holder.
  • The largest Windtree Therapeutics Inc buyer in Q2 2016 was UBS Group, an estimated $27.2K added.
  • The largest Windtree Therapeutics Inc seller in Q2 2016 was Sabby Management, an estimated $285K sold.

Based on aggregated 13F filings for Q2 2016.